BC
TXG icon

Bayforest Capital’s 10x Genomics TXG Stock Holding History

Bayforest Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
5,788
+5,246
+968% +$137K 0.21% 144
2026
Q1 		$11.5K Sell
542
-16,983
-97% -$340K 0.01% 783
2025
Q4 		$286K Sell
17,525
-54,302
-76% -$820K 0.21% 157
2025
Q3 		$840K Sell
71,827
-23,037
-24% -$300K 0.4% 33
2025
Q2 		$1.1M Buy
94,864
+69,306
+271% +$632K 0.48% 25
2025
Q1 		$223K Buy
25,558
+16,540
+183% +$209K 0.1% 368
2024
Q4 		$129K Buy
+9,018
New +$142K 0.16% 243

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bayforest Capital's TXG Position: Q2 2026 in Review

Bayforest Capital increased its 10x Genomics (TXG) stake by 968% in Q2 2026, buying an estimated $137K and bringing the position to 5,788 shares worth $222K. The position accounts for 0.21% of the portfolio, ranked #144.

Bayforest Capital first reported a position in TXG in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.1M in Q2 2025. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Bayforest Capital held 5,788 shares of 10x Genomics worth $222K as of Q2 2026.
  • Bayforest Capital bought 5,246 10x Genomics shares in Q2 2026, an estimated $137K.
  • 10x Genomics made up 0.21% of Bayforest Capital's portfolio in Q2 2026, its #144 holding.
  • Bayforest Capital first reported a position in 10x Genomics in Q4 2024 and has held it in 7 quarters since.
  • Bayforest Capital's 10x Genomics position peaked at $1.1M in Q2 2025.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.